Patents by Inventor Min Jae Joo

Min Jae Joo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11742097
    Abstract: The present disclosure relates to a pellet containing an oxide additive to improve a nuclear-fission-gas-adsorption ability of a uranium-dioxide pellet used as nuclear fuel and increase the grain size thereof, and to a method of manufacturing the same. A La2O3—Al2O3—SiO2 sintering additive is added to uranium dioxide so that mass movement is accelerated due to the liquid phase generated during sintering of the uranium-dioxide pellet, which promotes the growth of grains thereof. Further, since less volatilization occurs during sintering due to the low vapor pressure of the liquid phase, efficient additive performance is exhibited, so the liquid phase surrounding the grain boundary effectively adsorbs cesium, which is a nuclear fission gas.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: August 29, 2023
    Assignee: KEPCO NUCLEAR FUEL CO., LTD.
    Inventors: Kwang-young Lim, Tae-sik Jung, Yeon-su Na, Min-jae Joo, Seung-jae Lee, Yoon-ho Kim
  • Publication number: 20220223303
    Abstract: Proposed are nuclear fuel pellets showing high oxidation resistance in a steam atmosphere and a method for manufacturing same. The method includes: preparing a powder mixture by mixing a sintering additive powder including Cr2O3, MnO, and SiO2 with a uranium dioxide powder; forming a molded body by subjecting the powder mixture to compression molding; and sintering the molded body in a weak oxidative atmosphere in which an oxygen potential is ?581.9 kJ/mol to ?218.2 kJ/mol. The nuclear fuel pellets contain 0.05% to 0.16% by weight of the sintering additive composed of Cr2O3, MnO, and SiO2. A liquid phase generated during the sintering accelerates grain growth and inhibits reaction between uranium dioxide with steam by forming a film at the grain boundary of the uranium dioxide. This reduces leakage of a fission material by improving high-temperature water vapor oxidation resistance at around 1204° C. in a loss-of-coolant accident condition.
    Type: Application
    Filed: March 22, 2022
    Publication date: July 14, 2022
    Applicant: KEPCO NUCLEAR FUEL CO., LTD.
    Inventors: Kwang-young Lim, Tae-sik Jung, Yeon-su Na, Min-jae Joo, Seung-jae Lee, Yoon-ho Kim
  • Publication number: 20210304905
    Abstract: The present disclosure relates to a pellet containing an oxide additive to improve a nuclear-fission-gas-adsorption ability of a uranium-dioxide pellet used as nuclear fuel and increase the grain size thereof, and to a method of manufacturing the same. A La2O3—Al2O3—SiO2 sintering additive is added to uranium dioxide so that mass movement is accelerated due to the liquid phase generated during sintering of the uranium-dioxide pellet, which promotes the growth of grains thereof. Further, since less volatilization occurs during sintering due to the low vapor pressure of the liquid phase, efficient additive performance is exhibited, so the liquid phase surrounding the grain boundary effectively adsorbs cesium, which is a nuclear fission gas.
    Type: Application
    Filed: March 12, 2021
    Publication date: September 30, 2021
    Applicant: Kepco Nuclear Fuel Co., Ltd.
    Inventors: Kwang-young Lim, Tae-sik Jung, Yeon-su Na, Min-jae Joo, Seung-jae Lee, Yoon-ho Kim
  • Patent number: 10792285
    Abstract: The present invention relates to a pharmaceutical composition with enhanced stability, containing pemetrexed or a salt thereof, and a preparation method therefor. The present invention provides an injection preparation in liquid form containing pemetrexed, capable of ensuring sufficient stability during circulation and storage by selection of an optimum material and setting of an optimum concentration range in order to secure the stability of pemetrexed. The present invention can provide a pemetrexed preparation which is readily commercially prepared, can prevent microbial contamination occurring during lyophilization or reconstitution, and has enhanced convenience of administration and stability.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: October 6, 2020
    Assignee: Chong Kun Dang Pharmaceutical Corp.
    Inventors: Min Jae Joo, Hye Jin Seo, Shin Jung Park
  • Publication number: 20200261458
    Abstract: The present invention relates to a pharmaceutical composition with enhanced stability, containing pemetrexed or a salt thereof, and a preparation method therefor. The present invention provides an injection preparation in liquid form containing pemetrexed, capable of ensuring sufficient stability during circulation and storage by selection of an optimum material and setting of an optimum concentration range in order to secure the stability of pemetrexed. The present invention can provide a pemetrexed preparation which is readily commercially prepared, can prevent microbial contamination occurring during lyophilization or reconstitution, and has enhanced convenience of administration and stability.
    Type: Application
    Filed: December 13, 2016
    Publication date: August 20, 2020
    Inventors: Min Jae Joo, Hye Jin Seo, Shin Jung Park